Adicet Bio Inc. buy mixitrader
Start price
16.03.24
/
50%
€1.79
Target price
16.03.25
€19.00
Performance (%)
28.42%
End price
30.03.24
€2.30
Summary
This prediction ended on 30.03.24 with a price of €2.30. The BUY prediction by mixitrader finished with a performance of 28.42%. mixitrader has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Adicet Bio Inc. | -3.998% | -3.998% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
According to mixitrader what are the pros and cons of Adicet Bio Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
Top Rating
Very valuable balance sheet
ROE higher than 15% per year
Very good company culture
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Sustainability is very important
Management is a major shareholder
Market Leader or Top 3
Very small cyclical dependencies
Undervalued
Very high dividend yield expected
Very positive Cash Flow expected
High Investments for future growth
Small challenges to pay loans and raise capital
Very capable Management
Small Risks for its business
Well known brand
Very Future proof/growth oriented business model
Growths much faster than the competition
Cons
Comments by mixitrader for this prediction
In the thread Restorbio Inc. diskutieren
In the thread Trading Restorbio Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by mixitrader for Adicet Bio Inc.
Adicet Bio Inc.
Start price
Target price
Perf. (%)
€1.97
13.04.24
13.04.24
€20.00
13.04.25
13.04.25
-14.53%
01:00
01:00
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
Adicet Bio Inc.
Start price
Target price
Perf. (%)
€2.01
06.04.24
06.04.24
€21.00
06.04.25
06.04.25
-2.04%
13.04.24
13.04.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected